-
UBS Reiterates Buy Rating on Healthcare Services Group (HCSG)
-
Healthcare Services Group (HCSG) Sees MSD Top-Line Growth Ahead - UBS
-
Healthcare Services Group (HCSG) PT Raised to $24 at Benchmark
-
Healthcare Services Group (HCSG) Tops Q3 EPS by 38c
-
Benchmark Reiterates Buy Rating on Healthcare Services Group (HCSG) Ahead of Results
-
Macquarie Upgrades Healthcare Services Group (HCSG) to Outperform
-
Healthcare Services Group (HCSG) PT Raised to $19 at Benchmark
-
Healthcare Services Group (HCSG) Misses Q2 EPS by 64c
-
Benchmark Reiterates Buy Rating on Healthcare Services Group (HCSG)
-
HCSG expects $50M hit as Genesis HealthCare files for bankruptcy
-
UBS Upgrades Healthcare Services Group (HCSG) to Buy
-
Healthcare Services Group (HCSG) Tops Q1 EPS by 5c
-
Healthcare Services Group (HCSG) Misses Q4 EPS by 4c
-
Macquarie Starts Healthcare Services Group (HCSG) at Neutral
-
Healthcare Services Group (HCSG) Misses Q3 EPS by 2c ; Offers Guidance
-
Healthcare Services Group (HCSG) PT Raised to $14 at Baird
-
Healthcare Services Group (HCSG) PT Lowered to $14 at RBC Capital
-
Healthcare Services Group (HCSG) Reports In-Line Q2 EPS

